REG - ConvaTec Group PLC - Result of AGM
RNS Number : 3272MConvaTec Group PLC07 May 2020ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2020 - Poll Result
ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today ("Meeting"), The results of the poll held in relation to the resolutions proposed at the Meeting are set out below.
For
(see note 2)
Against
(see note 2)
Total Votes
% of ISC Voted
Number of Votes Withheld
(see note 3
Resolution
No of shares
%
No of Shares
%
1
Receive Annual Report and Accounts
1,689,253,478
99.99
162,424
0.01
1,689,415,902
85.17
1,375,861
2
Approve the Directors' Remuneration Report
1,459,271,427
86.35
230,658,135
13.65
1,689,929,562
85.20
908,684
3
Approve the Directors' Remuneration Policy
1,479,320,219
87.54
210,611,343
12.46
1,689,931,562
85.20
906,684
4
Declare Final Dividend
1,670,311,992
98.79
20,526,249
1.21
1,690,838,241
85.24
6
5
Elect John McAdam as a director
1,686,038,868
99.72
4,725,844
0.28
1,690,764,712
85.24
73,534
6
Elect Karim Bitar as a director
1,687,089,831
99.78
3,746,388
0.22
1,690,836,219
85.24
2,028
7
Elect Brian May as a director
1,689,080,374
99.90
1,749,450
0.10
1,690,829,824
85.24
8,423
8
Re-elect Frank Schulkes as a director
1,684,095,328
99.60
6,734,291
0.40
1,690,829,619
85.24
8,628
9
Re-elect Margaret Ewing as a director
1,662,219,417
98.31
28,611,702
1.69
1,690,831,119
85.24
7,128
10
Re-elect Rick Anderson as a director
1,686,272,799
99.73
4,561,920
0.27
1,690,834,719
85.24
3,528
11
Re-elect Regina Benjamin as a director
1,678,521,751
99.30
11,891,727
0.70
1,690,413,478
85.22
424,768
12
Re-elect Ros Rivaz as a director
1,630,402,633
96.47
59,672,747
3.53
1,690,075,380
85.21
762,866
13
Re-elect Sten Scheibye as a director
1,687,084,151
99.78
3,745,468
0.22
1,690,829,619
85.24
8,628
14
Re-appoint Deloitte LLP as auditor
1,690,827,240
100.00
9,746
0.00
1,690,836,986
85.24
1,261
15
Authorise the directors to determine the remuneration of the Company's auditor
1,690,692,456
100.00
5,000
0.00
1,690,697,456
85.24
140,791
16
Authorise political donations and political expenditure
1,679,778,558
99.35
11,050,957
0.65
1,690,829,515
85.24
8,732
17
Authorise allotment of shares
1,576,731,448
93.28
113,598,212
6.72
1,690,329,660
85.22
508,587
18
Disapply pre-emption rights*
1,665,615,258
98.53
24,844,432
1.47
1,690,459,690
85.23
378,557
19
Disapply pre-emption rights in connection with an acquisition or specified capital investment*
1,664,010,440
98.44
26,449,249
1.56
1,690,459,689
85.23
378,557
20
Authorise purchase of own shares*
1,669,151,425
98.76
20,937,729
1.24
1,690,089,154
85.21
749,092
21
Call general meetings on 14 days' notice*
1,663,148,185
98.36
27,687,156
1.64
1,690,835,341
85.24
2,906
*Special Resolution
NOTES:
1. All resolutions were passed.
2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 6 May 2020 was 1,983,513,851 shares; 85.24% of voting capital was instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRAGUBAVRRRUVRAR
Recent news on ConvaTec
See all newsREG - Convatec Group PLC - Holding(s) in Company
AnnouncementREG - Convatec Group PLC - Holding(s) in Company
AnnouncementREG - Convatec Group PLC - Posting of Annual Report and Notice of Meeting
AnnouncementREG-Convatec Group PLC Convatec Group PLC: Director/ PDMR Shareholding
AnnouncementREG - ConvaTec Group PLC - Annual Results
Announcement